Mineralys Therapeutics, Inc. MLYS Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Mineralys Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s earnings yield?
- Mineralys Therapeutics, Inc. (MLYS) reported earnings yield of -6.8% in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s earnings yield changed year-over-year?
- Mineralys Therapeutics, Inc.'s earnings yield increased by 64.0% year-over-year, from -18.9% to -6.8%.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s earnings yield?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s earnings yield has grown at a -49.2% compound annual growth rate (CAGR), from -20.9% to -5.4%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.